Research peptide · product 01
Retatrutide
30 mg pen
Advanced dual-chamber research pen
A triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors. Pre-filled, precision-filled, verified pure.
For qualified research and laboratory purposes where permitted by applicable law. Batch-specific specifications should be verified against the relevant documentation.
Technical specification
Precision in every detail.
Information may vary by batch. Refer to the corresponding Certificate of Analysis and product documentation for verified, batch-specific information.
Product
Retatrutide
Total content
30 mg
Format
Advanced dual-chamber pen
Purity
>99% where supported by batch documentation
Testing
US laboratory tested
Documentation
Certificate of Analysis
Manufacturing
Made in USA
Technology
Dual-chamber
Handling
Cold-chain controlled where applicable
Batch verification
See batch-specific COA
Device architecture
One research format. Two perspectives.
Research mechanism
Three receptors. One research peptide.
Retatrutide is described in research literature as a triple agonist involving GIP, GLP-1 and glucagon receptor pathways. This context is presented for research biology—not clinical use.
01
GIP receptor
A peptide hormone receptor pathway studied in metabolic signaling research.
02
GLP-1 receptor
A well-characterized research target for studying peptide-mediated receptor activity.
03
Glucagon receptor
A receptor pathway included in the triple-agonist research design of retatrutide.